Digital therapeutics refers to the use of evidence-based therapeutic interventions driven by high-quality software programs to treat, manage, or prevent a medical condition. This approach is being increasingly investigated for the management of hypertension, a common condition that is the leading preventable cardiovascular disease risk factor worldwide. Digital interventions can help facilitate uptake of important guideline-recommended lifestyle modifications, reinforce home blood pressure monitoring, decrease therapeutic inertia, and improve medication adherence. However, current studies are only of moderate quality, and are highly heterogeneous in the interventions evaluated, comparator used, and results obtained. Therefore, additional studies are needed, focusing on the development of universally applicable and consistent digital therapeutic strategies designed with health care professional input and evaluation of these interventions in robust clinical trials with objective end points. Hopefully, the momentum for digital therapeutics triggered by the coronavirus disease 2019 pandemic can be utilized to maximize advancements in this field and drive widespread implementation.

中文翻译：

---

高血压的数字疗法：证据和观点

数字疗法是指使用由高质量软件程序驱动的循证治疗干预来治疗、管理或预防医疗状况。越来越多地研究这种方法来治疗高血压，这是一种常见的疾病，是全球主要的可预防心血管疾病风险因素。数字干预有助于促进重要的指南推荐的生活方式改变，加强家庭血压监测，减少治疗惰性，并提高药物依从性。然而，目前的研究质量中等，并且在评估的干预措施、使用的比较器和获得的结果方面存在高度异质性。因此，需要额外的研究，专注于开发普遍适用和一致的数字治疗策略，设计与医疗保健专业人员的投入和在具有客观终点的稳健临床试验中评估这些干预措施。希望能够利用由 2019 年冠状病毒病大流行引发的数字疗法的势头来最大限度地提高该领域的进步并推动广泛实施。